Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin-A Compared with Cetirizine in the Treatment of Allergic Rhinitis
IRCT201208261579N3Phase 2Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Dec 2010
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of botulinum toxin type A and cetirizine in allergic rhinitis (AR) (2 arms), sponsored by Isfahan University of Medical Sciences. Started Dec 2010; status: completed.
02
Drugs
botulinum toxin type Acetirizine
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on IRCT201208261579N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201208261579N3.